Heart
Risks and Metabolic Syndrome Linked
A cluster of cardiac
factors known as "metabolic syndrome" is
a strong indicator of increased risk of heart disease, according to a report
in the Journal of the American College of Cardiology
(JACC).
Metabolic syndrome
includes factors such as lower-abdomen obesity, high blood pressure, blood
fat disorders such as high LDL ("bad")
cholesterol, and insulin resistance or elevated blood sugar levels.
Generally,
someone with three or more of these factors is said to have metabolic syndrome.
"The question has been for a number of years what the risk
associated with metabolic syndrome is," says study author Dr. Apoor S. Gami,
an assistant professor of medicine at the Mayo Clinic College of Medicine.
"What is the quantified risk in patients with metabolic
syndrome? That is one question we could answer by meta-analysis," says Dr.
Gami.
A meta-analysis crunches data from a host of prior studies
to come to a more solid conclusion.
This analysis of 37 studies included more than 170,000 individuals.
Dr. Gami not only analyzed published studies, but also sought more detailed
information from the researchers who did the studies.
The meta-analysis found the risk of heart attack or death
was 78 percent higher for people with metabolic syndrome than those who did
not have this constellation of risk factors.
"The main take-away from this study is that people identified
with metabolic syndrome, regardless of the criteria used to describe metabolic
syndrome, are at increased risk of cardiac events or death," explains Dr. Gami.
"There
is anywhere from a 50 percent to 200 percent increase in risk, which seems
to be stronger in women," he says.
The implication for medical practice is that anyone with
metabolic syndrome needs extra attention for preventive measures, says Dr.
Gami. The finding comes as something less than a surprise, notes
Dr. Robert Eckel, a professor of medicine at the University of Colorado.
"Many of us in the field have felt that it [metabolic syndrome]
is important for some time now," says Dr. Eckel.
But there is ongoing
debate about "how you define metabolic
syndrome in terms of threshold values," he says. "This is a syndrome, not a
disease. We still need to learn more about its components and how we can define
them better."
While
Dr. Eckel says the new study provides "additional
evidence for the value of metabolic syndrome," a dissenting view came from
Dr. Michael Stern, at the University of Texas Health Science Center at San
Antonio. He has written skeptical reports on the importance of metabolic
syndrome, including one for the American Diabetes Association.
"There is no doubt that metabolic syndrome is associated
with increased cardiovascular risk," says Dr. Stern. "The question is whether
it is the best way to identify that risk.
"There are other established methods of identifying high-risk
individuals that are not related to metabolic syndrome," he says.
According to Dr.
Stern, an equation derived from the long-running Framingham Heart Study provides
a better risk assessment than the metabolic
syndrome, which is "an arbitrary collection of risk factors.
"If the goal is to identify high-risk individuals, you can
do just as well or better with the Framingham equation," he says.
But the presence of the metabolic syndrome provides better
evidence of risk than taking individual components of the syndrome one by one,
Dr. Gami counters.
"Three studies addressed this, and the risk was increased
by 50 percent above those of the individual risk factors that were present," says
Dr. Stern.
Always consult your physician for more information.
|
